Total Payments
$8,162
2024 Payments
$1,286
Companies
42
Transactions
551
Medicare Patients
1,631
Medicare Billing
$121,606
Payment Breakdown by Category
Food & Beverage$8,047 (98.6%)
Education$114.83 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,047 | 540 | 98.6% |
| Education | $114.83 | 11 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,126 | 67 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,076 | 70 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $587.13 | 23 | $0 (2023) |
| Merck Sharp & Dohme LLC | $569.50 | 47 | $0 (2024) |
| PFIZER INC. | $556.87 | 46 | $0 (2024) |
| GlaxoSmithKline, LLC. | $478.42 | 34 | $0 (2024) |
| ABBVIE INC. | $449.41 | 30 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $438.59 | 39 | $0 (2020) |
| Lilly USA, LLC | $345.85 | 23 | $0 (2024) |
| Amgen Inc. | $325.19 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,286 | 71 | ABBVIE INC. ($261.98) |
| 2023 | $457.78 | 24 | AbbVie Inc. ($137.75) |
| 2022 | $56.92 | 3 | Novo Nordisk Inc ($39.04) |
| 2021 | $49.68 | 3 | AbbVie Inc. ($49.68) |
| 2020 | $476.60 | 28 | Novo Nordisk Inc ($108.74) |
| 2019 | $2,116 | 137 | Boehringer Ingelheim Pharmaceuticals, Inc. ($398.87) |
| 2018 | $1,985 | 150 | Boehringer Ingelheim Pharmaceuticals, Inc. ($342.75) |
| 2017 | $1,734 | 135 | Novo Nordisk Inc ($252.17) |
All Payment Transactions
551 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Diabetes Care | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: PAIN | ||||||
| 10/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $2.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Inflammation | ||||||
| 10/07/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY, BEXSERO | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: VACCINES | ||||||
| 09/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Obesity | ||||||
| 09/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.28 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Endocrinology | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Obesity | ||||||
| 08/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: PAIN | ||||||
| 07/31/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.92 | General |
| Category: PSYCHIATRY | ||||||
| 07/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 101 | 108 | $16,547 | $3,585 |
| 2022 | 3 | 430 | 585 | $66,717 | $23,229 |
| 2021 | 6 | 537 | 810 | $84,790 | $50,435 |
| 2020 | 7 | 563 | 837 | $94,821 | $44,357 |
Total Patients
1,631
Total Services
2,340
Medicare Billing
$121,606
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 68 | $7,467 | $1,899 | 25.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 40 | 40 | $9,080 | $1,686 | 18.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 178 | 265 | $25,705 | $9,990 | 38.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 127 | 195 | $12,637 | $7,705 | 61.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 125 | 125 | $28,375 | $5,534 | 19.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 221 | 367 | $36,520 | $22,771 | 62.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 107 | 107 | $24,289 | $14,100 | 58.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 138 | 245 | $15,751 | $10,992 | 69.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 32 | 51 | $6,936 | $2,242 | 32.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 13 | $403.00 | $176.33 | 43.8% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 26 | 27 | $891.00 | $152.95 | 17.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 204 | 353 | $34,806 | $16,735 | 48.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 142 | 142 | $32,234 | $16,285 | 50.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 123 | 222 | $14,223 | $7,470 | 52.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 60 | 79 | $9,585 | $2,769 | 28.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 11 | 13 | $2,628 | $761.21 | 29.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 11 | 16 | $949.10 | $275.79 | 29.1% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2020 | 12 | 12 | $396.00 | $61.18 | 15.4% |
About Dr. Steven Balsamo, DO
Dr. Steven Balsamo, DO is a Family Medicine healthcare provider based in Clifton Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013977438.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Balsamo, DO has received a total of $8,162 in payments from pharmaceutical and medical device companies, with $1,286 received in 2024. These payments were reported across 551 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($8,047).
As a Medicare-enrolled provider, Balsamo has provided services to 1,631 Medicare beneficiaries, totaling 2,340 services with total Medicare billing of $121,606. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Clifton Park, NY
- Active Since 03/28/2006
- Last Updated 05/06/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1013977438
Products in Payments
- JANUVIA (Drug) $411.20
- JARDIANCE (Drug) $397.04
- Ozempic (Drug) $378.03
- CHANTIX (Drug) $349.09
- VRAYLAR (Drug) $322.62
- XARELTO (Drug) $316.45
- Victoza (Drug) $290.10
- FARXIGA (Drug) $231.78
- TRADJENTA (Drug) $227.58
- Saxenda (Drug) $208.06
- BREO (Drug) $188.71
- STIOLTO RESPIMAT (Drug) $188.56
- ENTRESTO (Drug) $178.85
- SPIRIVA RESPIMAT (Drug) $151.06
- SYMBICORT (Drug) $125.12
- UBRELVY (Drug) $122.33
- INVOKANA (Drug) $122.14
- TRELEGY ELLIPTA (Drug) $120.97
- Tresiba (Drug) $118.49
- Otezla (Drug) $112.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Clifton Park
Renata Mazzei -Klokiw, Md, MD
Family Medicine — Payments: $12,447
Family Medicine $12,447
Antonio Gregorian, Md, MD
Family Medicine — Payments: $10,175
Family Medicine $10,175
Renee Argubano, Md, MD
Family Medicine — Payments: $8,942
Family Medicine $8,942
Matthew Cunningham, Md, MD
Family Medicine — Payments: $7,234
Family Medicine $7,234
Dr. Steffani Cotugno, D.o, D.O
Family Medicine — Payments: $7,025
Family Medicine $7,025
Neema Afejuku-Adelaja, M.d, M.D
Family Medicine — Payments: $5,534
Family Medicine $5,534